In this PharmaTimes article, Duncan Arbour, SVP Innovation at Syneos Health Communications Europe, talks about the need for being faster to what really matters and finding the right protocols for patients.
He elaborates that site selection and patient targeting require more than just hard data on patients’ treatment pathways; they also need an equal focus on the very human process of understanding patients’ emotional pathways – the nuances of their personal disease experience and the uniqueness of each patient’s ability to cope both physically and mentally with their treatment options.
This content was repurposed from PharmaTimes.
